Reagents bioMérieux’s reagents are intended for in vitro use. The compliance of the reagents with the specifications indicated on the package insert is guaranteed until expiry date.
Reagents. Subject to the terms and conditions of this Agreement, including but not limited to this Section 5.4 and Exhibit C, Illumina hereby appoints CareDx as its non-exclusive distributor for the re-Sale of Illumina [...***...] Reagents during the Term for use in the Licensed Field only, subject to the following additional restrictions on CareDx and any third parties that are re-Selling or using Illumina [...***...] Reagents purchased under this Agreement:
Reagents. All remaining reagents stored at 2-8C, -20C and -80C. Reagents for KBRV201 include expression vectors for production of intact KBRV201 antibody by transient transfection of mammalian cell lines. KBAB401 Cell lines (MCB, RCB and cell lines) Cell lines Location All KBAB401 hybridoma and LCL cell lines (uncharacterized) Kenta Biotech, Schlieren, CH Reagents All remaining human PBLS stored in LN2 and all patient sera stored at -20C (see document “Freezer Content”). Portions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended General Cell lines Cell lines Location LA55 fusion partner cell line (RCB) Kenta Biotech, Schlieren, CH HL60 phagocytic cell line Kexxx Xxxxxxx, Xxxxxxxxx, XX X00-0 XBV secreting cell line Kenta Biotech, Schlieren, CH EL4-B5 murine feeder cell line Kenta Biotech, Schlieren, CH Patients PBL Kenta Biotech, Schlieren, CH Commercially available cell lines (Jurkat, HEK293, etc.) Kenta Biotech, Schlieren, CH See list of LN2 storage tank Kenta Biotech, Schlieren, CH Kenta Biotech, Schlieren, CH Reagents All remaining reagents stored at 2-8C, -20C and -80C (see document “Freezer Content”), including clinical isolates of viruses (RSV) and bacteria (P. aeruginosa, S. aureus, A. baumannii); Patients sera and clinical isolates (BAL, ETA and sputum) from all research activities. Portions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended Schedule B List of Contracts KBSA301-001 FIH CT Operational Partner: · ORION Clinical Services Limited, 7 Xxxx Xxxx, Xxxxxx, Xxxxxxx XX0 0XX · Xxxxxx Clinical Services Switzerland, Stxxxxxxxxxx 00, 0000 Xxxxxxxxx / Xxxxxxxxxxx · Cenduit LLC, Chelsea Place, 1000 Xxxxxx Xxxx, Suite 301, Durham, NC 27703, USA · Eurofins Medinet B.X., Xxxxxxxxx 00, 0000 XX, Xxxxx, xxx Xxxxxxxxxxx Details: Partner Title Effective date ORION Amendment No 5 to Work Order 001 expected Amendment No 4 to Work Order 001 Mar 27, 2013 Amendment No 3 to Work Order 001 Mar 26, 2013 Amendment No 2 to Work Order 001 Feb 1, 2013 Amendment No 1 to Work Order 001 Feb 1, 2013 Work Order 001 Feb 1, 2012 Master Study Agre...
Reagents. Isis shall charge the Collaboration Funds for Reagent ASO Compounds provided to Lilly by Isis under the Reagent Provision Program at the Isis HTS Standard Cost or Isis RTS Standard Cost, as applicable, in accordance with the provisions of Section 9.1.1.
Reagents. Any service calls necessitated by poor quality reagent in the circumstances set out in this clause 6 will not be covered by the annual service fee payable by the Customer to Xxxxxxx Xxxxxxx in accordance with clause 4 of this Agreement. Where a problem occurs as a result of the poor quality of a reagent that has not been supplied by Xxxxxxx Xxxxxxx in circumstances where:
Reagents. All Intellectual Property Rights in the Reagents remain at all times vested in the Third Party Contractor. The Recipient must only use the Reagents in accordance with this Agreement. The Recipient must not, and must ensure that its Recipient Personnel do not, modify the Reagents.
Reagents. (a) Buyer herby covenants that it and each of its Affiliates will not (a) transfer to the United States or sell within the United States any (i) Products or (ii) other goods that (1) contain or are derivate of cell lines subject to paragraph 4 of the Consent Decree or (2) contain any Reagents supplied by Seller and its Affiliates that have not been created within the United States or (3) contain the Reagent 84165 S Pan-1; Hollow Fiber Harvest (“Prohibited Goods”) and (b) will use best efforts to prevent its representatives, agents, successors and assigns from transferring Prohibited Goods to or selling Prohibited Goods in the United States (including by the immediate termination or expiration of sales to distributors to the extent necessary to comply herewith); provided, however, that solely in the case of Products or other goods that contain any Reagents supplied by Seller and its Affiliates that have been created within the United States (other than Reagent 84165 S Pan-1; Hollow Fiber Harvest) this covenant shall not prohibit the transfer to or sale of such Products or other goods if (A) the FDA has first provided confirmation reasonably satisfactory to Seller that transfer or sale in the United States is acceptable to the FDA or (B) the restrictions imposed upon Seller with respect to a particular Prohibited Good under the Consent Decree has expired, lapsed or otherwise terminated. Buyer further acknowledges that because a breach, or failure to comply with, this Section 5.7(a) will cause irreparable injury to Seller for which there is no adequate remedy by Law and the exact amount of which will be difficult to ascertain, if Buyer, or any Affiliate, representative, agent successor or assign thereof, should in any way breach, or fail to comply with, the terms of this Section 5.7(a), Seller shall be immediately entitled to an injunction restraining such Person(s) from any such breach or failure, without the necessity of proving injury or damages or engaging in the alternative dispute resolution process set forth in the Asset Purchase Agreement. Resort of any such remedy provided for by Law shall not preclude or bar the concurrent or subsequent employment of any other appropriate remedy or remedies, or preclude the recover by Seller of monetary damages and compensation.
Reagents. RDS shall supply ANSYS with the reagents necessary to manufacture the No-Step Kit.
Reagents. Item Supplier Agarose Sigma-Aldrich, Gillingham, UK 10XTBE Buffer Invitrogen Ltd, Paisley, UK Ethidium bromide Sigma-Aldrich, Gillingham, UK Loading dye Sigma-Aldrich, Gillingham, UK 100 bp ladder Invitrogen Ltd, Paisley, UK
Reagents. The Contractor shall be permitted the addition of reagents to the Centrate during processing if identified as an inherent part of the selected ammonia recovery processing technology. Reagents may include but not be limited to zinc sulfate and sulfuric acid which are used in the ammonia recovery process system. Reagents are subject to approval by the City prior to addition to the Contractor’s ammonia recovery processing system. Under no circumstance shall the Contractor be permitted to use a reagent that is a regulated waste, unless the Contractor receives prior approval from the regulatory agency(ies) maintaining jurisdiction over the Contractor’s processing facility and the Contractor can demonstrate to the City an apparent benefit in using the material in its process.
